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Abstract—This study aims to develop an automatic classifier for
risk assessment in patients suffering from congestive heart failure
(CHF). The proposed classifier separates lower risk patients from
higher risk ones, using standard long-term heart rate variability
(HRV) measures. Patients are labeled as lower or higher risk ac-
cording to the New York Heart Association classification (NYHA).
A retrospective analysis on two public Holter databases was per-
formed, analyzing the data of 12 patients suffering from mild CHF
(NYHA I and II), labeled as lower risk, and 32 suffering from
severe CHF (NYHA III and IV), labeled as higher risk. Only pa-
tients with a fraction of total heartbeats intervals (RR) classified as
normal-to-normal (NN) intervals (NN/RR) higher than 80% were
selected as eligible in order to have a satisfactory signal quality.
Classification and regression tree (CART) was employed to de-
velop the classifiers. A total of 30 higher risk and 11 lower risk
patients were included in the analysis. The proposed classification
trees achieved a sensitivity and a specificity rate of 93.3% and
63.6%, respectively, in identifying higher risk patients. Finally, the
rules obtained by CART are comprehensible and consistent with
the consensus showed by previous studies that depressed HRV is a
useful tool for risk assessment in patients suffering from CHF.
Index Terms—Congestive heart failure (CHF), data mining,
decision tree, heart rate variability (HRV).
I. INTRODUCTION
CONGESTIVE heart failure (CHF) is a pathophysiologicalcondition due to an abnormal cardiac function, which is
responsible for the failure of the heart to pump blood as re-
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quired by the body. CHF severity can be measured with the
symptomatic classification scale of the New York Heart Asso-
ciation (NYHA) [1]. Classification via NYHA scale has been
proved to be a risk factor for mortality [2], [3].
Heart rate variability (HRV) is the variation over time of
the period between consecutive heartbeats (RR intervals) [4]
and is usually extracted from electrocardiographic signal (ECG)
recorded through a noninvasive technique. HRV is commonly
used to assess the influence of the autonomic nervous system
(ANS) on the heart [5]. HRV has been widely studied in patients
suffering from CHF [6]–[19]. Many studies demonstrated that
HRV is an effective means for the risk assessment of mortality
[8], [10], [13]–[15], [17].
A number of studies [6], [7], [11], [12], [18] demonstrated
the relationship of HRV measures and the NYHA classifica-
tion scale. In our previous papers, we demonstrated that HRV
might be used to detect CHF using short-term [20] or long-term
measures [21]. Moreover, we proposed a classifier based on
short-term HRV measures to individuate severity of CHF [22].
Over the past years, automatic classifiers, based on several
clinical and instrumental parameters, have been proposed to sup-
port CHF assessment [23]. However, to the best of the authors’
knowledge, these classifiers are not based on HRV features, ex-
cept for those proposed by Yang et al. [24] who included HRV
features but did not provide details about the related processing.
In this study, we present a classifier, based on long-term HRV
measures, for the individuation of high-risk conditions in CHF
patients, estimated via NYHA scale. Patients where considered
at higher risk if suffering from severe CHF (NYHA III or IV)
and at lower risk if suffering from mild CHF (NYHA I or II).
The method we used to develop the classifier is classification
and regression tree (CART). CART, developed by Breiman [25],
has been used in several applications of pattern recognition es-
pecially for medical diagnosis [26]. The CART algorithm itera-
tively splits the dataset, according to a criterion that maximizes
the separation of the data, producing a tree-like decision struc-
ture [25]. CART was applied to HRV measures for other inves-
tigations [27]. We adopted CART in previous studies [20], [28],
in which a larger dataset was available to train the CART and/or
the final classification of the patients was based on a combina-
tion of trees. On the contrary, in this study, the selected dataset
is small and unbalanced. A number of solutions to the class-
imbalance problem were previously proposed at data, feature
selection, and algorithmic levels [29]. At the data level, these
solutions include many different forms of resampling. At the
algorithmic level, solutions include adjusting the costs of the
2168-2194/$31.00 © 2013 IEEE
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various classes so as to counter the class imbalance, adjusting
the probabilistic estimate at the tree leaf (when working with
decision trees) and adjusting the decision threshold. As regards
feature selection, Zheng et al. [30] proposed a framework to
deal with imbalanced dataset, showing the importance of fea-
ture selection methodology and performance measurement.
In this study, we adopted CART algorithms with a feature
selection algorithm in order to handle a small and unbalanced
dataset. We compared the performance of the proposed method
with a standard data-level-based method to deal with imbalance
that is the oversampling technique. We preferred a data-level
solution as the benchmark since the algorithmic level solutions
require the probability and the misclassification cost of the class
that are difficult to estimate particularly in this case, as the rare
class is also the milder one. Moreover, we compared the results
of the proposed method with other classifiers based on decision
trees, i.e., C4.5 [31] and random forest (RF) [32].
We implemented decision trees as they provide a classification
model, i.e., “if . . . then” rules, which can be easy to read and
interpret. This is crucial in medical applications [33] in which
the physician is personally responsible of the diagnosis.
The HRV measures were extracted from two Holter monitor
public databases [34] by using only open source and validated




We analyzed 44 nominal 24-h recordings from 12 lower risk
patients (LRPs) suffering from mild CHF (NYHA Classes I and
II) and 34 higher risk patients (HRPs) suffering from severe CHF
(NYHA Classes III and IV). Only patients with a satisfactory
signal quality, as described in the Section II-B, were selected as
eligible. The data were retrieved from the Congestive Heart Fail-
ure RR Interval Database [34] and from the BIDMC Congestive
Heart Failure Database [34]. The former database includes RR
intervals extracted from 24-h ECG-Holter recordings of 8 men,
2 women, and 19 unknown-gender subjects, aged 34–79 years
(55 ± 11 years). The original ECG recordings were digitized at
128 samples per second, and the beat annotations were obtained
by automated analysis with manual review and correction. The
latter database includes long-term ECG recordings from 11 men
and 4 women, aged 22–71 years (56± 11 years). The recordings
were sampled at 250 samples per second and were automatically
annotated. There were no significant differences between the
two database in terms of age (t-test p-value: 0.85) and gender
(exact Fisher’s test p-value: 0.83) profiles.
B. Long-Term HRV Measures
We performed standard long-term HRV analysis on nominal
24-h recordings according to International Guidelines [5]. The
series of normal-to-normal (NN) beat intervals were obtained
from the beat annotation files of the selected databases and
the NN/RR ratio was computed as the fraction of total RR
intervals classified as NN. This ratio has been used as a measure
of data reliability, excluding recordings with a ratio less than
a threshold. We chose the threshold of 80% [34] as it was a
satisfactory tradeoff between numbers of included subjects and
quality of NN signals. Using this technique, 3 recordings were
excluded (1 LRPs and 2 HRPs) and the final dataset consisted
of 41 subjects: 11 LRP and 30 HRPs. There were no significant
differences between the two subsamples (LRPs versus HRPs) in
terms of age profile (t-test p-value: 0.11). Comparison of gender
is not possible as this information is not available in the LRPs.
All the computed basic time- and frequency-domain HRV
measures were widely used in literature as reported in Inter-
national Guidelines [4] and in a recent review on HRV [5]. A
number of standard statistical time-domain HRV measures were
calculated: AVerage of all NN intervals (AVNN); standard de-
viation of all NN intervals (SDNN); standard deviation of the
averages of NN intervals in all 5-minute segments of a 24-h
recording (SDANN); mean of the standard deviations of NN
intervals in all 5-minute segments of a 24-h recording (SDNN
IDX); square root of the mean of the sum of the squares of
differences between adjacent NN intervals (RMSSD); and per-
centage of differences between adjacent NN intervals that are
longer than 50 ms (pNN50). Moreover, pNN10 (that is, percent-
age of differences between adjacent NN intervals that are longer
than 10 ms) was computed because Mietus et al. [7] showed that
among the family of pNNx measures, pNN10 can provide the
maximum separation.
The frequency-domain HRV measures rely on the estima-
tion of power spectral density (PSD) computed in this work
by Lomb–Scargle (LS) periodogram [35]. Fast implementa-
tion and further detail of LS periodogram can be found else-
where [35]–[37]. After PSD estimation, six standard frequency-
domain HRV measures were calculated: total spectral power
of all NN intervals up to 0.4 Hz (TOTPWR); between 0 and
0.003 Hz (ULF); between 0.003 and 0.04 Hz (VLF); between
0.04 and 0.15 Hz (LF); between 0.15 and 0.4 Hz (HF); and ratio
of low- to high-frequency power (LF/HF).
C. Statistics
Since not all the HRV measures were normally distributed
[38], the data were reported in terms of median, 25th and 75th
percentiles, in order to describe distribution of measures in the
two groups (LRPs versus HRPs) and univariate differences were
assessed by Wilcoxon test.
D. Feature Selection
Even if CART implements a stepwise feature selection, it
may happen that one feature is excluded because other vari-
ables masked its effect. This could be particularly critical in
small and unbalanced dataset. In order to deal with masking
and to be sure that the tree included the best subset of features,
we adopted the so-called exhaustive search method [39], inves-
tigating all the possible combinations of k out of N features
(with k from 1 to N). Since the number of features N is 13, we
investigated 213 = 8092 subsets of features, training and testing
the same number of classifier, as further discussed. Among the
8092 classifiers, we choose the one with the lowest value of
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the misclassification error estimated by tenfold cross-validation
approach, as described in the following paragraph. Even if the
cross-validated estimate could provide limited information in
small and imbalanced dataset, the feature selection improves
the classification since it enables to consider combination of n
feature with n smaller than the size of available samples.
E. CART Method
The CART algorithm consists of two stages: tree growing and
tree pruning [25]. In the former stage, the tree grows by selecting
among all the possible splits, which generate the “purer” child
nodes where the purest node is the one containing elements
of only one class. The outcome of this step is further referred
to as the large tree (LT). Among different functions that have
been proposed for the measure of the impurity of each node
“t” [25], we adopted the Gini index criterion [25], which for
binary classification can be computed as follows:









where “t” is the considered node, “i” and “j” are the two class
labels, “ni” and “nj ” are the number of subject present at the
node belonging to the class “i” or “j,” respectively, and “n” is
the number of subject present at the node.
In the latter stage, the LT is pruned according to a minimal
cost-complexity function, which relies on the tree size and the
misclassification error. The misclassification error is estimated
by the inner tenfold cross-validation of the CART. The dataset is
randomly divided into ten subsets. One of the subsets is used as
independent testing dataset while the other nine subsets are used
as training dataset. The tree-growing and pruning procedure is
repeated ten times, each time with one of the ten different subsets
used as a testing set. The misclassification error is calculated as
the percentage of misclassified cases averaged over all the ten
subsets.
This procedure is repeated pruning the tree, and for each
subtree, the cost complexity function is computed as a linear
combination of the number of nodes and of the cross-validated
estimated of the misclassification error. The outcome of this
stage is referred further to as the best subtree (BST), which is
the subtree achieving the lowest value of the cost-complexity
function. Further details about minimal cost-complexity pruning
can be found in Breiman [25].
The most common measures for binary classification were es-
timated by tenfold cross-validation, using the formulas reported
in Table I, in particular F1 is one of the most suitable metric
for imbalanced class problem, as it is the harmonic mean of
precision and sensitivity (recall).
F. Benchmarks
We compared the method proposed in this paper with a
standard approach for class-imbalance problem based on over-
sampling that is the synthetic minority oversampling technique
(SMOTE). The rare class (mild CHF) was oversampled by cre-
ating new synthetic rare class samples according to each rare
class sample and its k nearest neighbors. Different values of the
TABLE I
BINARY CLASSIFICATION PERFORMANCE MEASURES
parameter k (from 2 to 8) were tested and the value with the
higher F1 measure was selected. As classifiers, we also adopted
two other decision-tree-based methods: C4.5 [31] and RF [32].
G. Implementation Details
The HRV extraction and analysis was performed using Phys-
ioNet’s HRV Toolkit [34]. We chose this toolkit as it is an open
source and a rigorously validated package. In particular, the im-
plementation of the LS periodogram adopted in this paper is the
lomb.c program available from Physionet [36].
The feature selection and classification were performed by
in-house software developed in MATLAB version R2009b (The
MathWorks, Inc., Natick, MA, USA). In particular, CART was
implemented by utilizing the methods and construction of the
MATLAB class classregtree. The benchmark methods were im-
plemented in Weka.
III. RESULTS
Table II shows the descriptive statistics of HRV measures
in LRPs and HRPs. Among time-domain measures, SDNN,
SDANN, SDNN IDX, and RMSSD were significantly reduced
in HRPs. All the frequency-domain measures were significantly
depressed in HRPs with the only exception of LF/HF.
The performance of the proposed method and benchmarks
are reported in Table III. The proposed method achieved higher
values of F1 measure and accuracy than the benchmarks. The
higher performances were obtained by two different combina-
tions of features: “TOTPWR, pNN10, pNN50, SDNNIDX” and
“ULF, TOTPWR, pNN50.”
The selected BSTs are represented in Figs. 1 and 2. Each
terminal node is the graphical representation of a set of “if . . .
then” rules. For instance, the terminal node 2 in the Fig. 1 can be
read as: “if TOTPWR is lower than 11080.25 ms2 , the subject
is classified as a higher risk patient.”
In the model shown in Fig. 1, the initial variable selected by
CART (at node 1 split) was TOTPWR. The subjects whose
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TABLE II
COMPARISON OF HRV BETWEEN THE TWO GROUPS
TABLE III
CLASSIFICATION PERFORMANCE MEASUREMENTS OF THE SELECTED CLASSIFIER ESTIMATED BY TENFOLD CROSS-VALIDATION
TOTPWR is lower than 11080.25 ms2 were all correctly
classified as HRPs. CART selected pNN50 for the second node
split. In this node split, the subjects whose pNN50 were lower
than 1.22% were classified as LRPs. Otherwise, the following
classification split was based on pNN10, that is, if it is lower
than 36.093%, the subject was classified as HRP; otherwise, a
final classification split is based on SDNNIDX with a threshold
of 100.910 ms2 .
In the model shown in Fig. 2, the initial variable selected
by CART (at node 1 split) was ULF. The subjects whose
ULF is higher than 21026.850 ms2 were correctly classified
as LRPs. CART selected TOTPWR for the second node split. In
this node split, the subjects whose TOTPWR were lower than
11080.250 ms2 were classified as HRPs. A final classification
split is based on pNN50, that is, if it is lower than 1.22%, the
subject was classified as LRP, otherwise as HRP.
IV. DISCUSSION
In this study, we developed a classification tree based on
standard long-term HRV for risk assessment in patients suffering
from CHF.
The classifiers based on the combinations of standard long-
term HRV measures “TOTPWR, pNN10, pNN50, SDNNIDX”
and “ULF, TOTPWR, PNN50” enable distinguishing HRPs
from LRPs with an accuracy rate of 85.4%, a sensitivity rate of
93.3%, and a specificity rate of 63.6% (tenfold cross-validation
estimates). The existence of these two best combinations can be
explained by the high correlation between HRV measures [5],
[38].
The selection of pNN10 in the best combination would con-
firm its discrimination power proved by Mietus et al. [7], even
if the differences in pNN10 values between the two groups were
lower than those of other measures, as shown by the statistical
analysis performed in the current study. As concerns pNN50,
Mietus et al. [7] showed that pNN50 failed to distinguish the
LRPs and HRPs, while pNN50 is used in the BSTs (see Fig. 1
node 2 and Fig. 2 node 4). This apparent inconsistency may be
explained by considering that pNN50 could have a discrimina-
tive power only for the subgroups of patients which had high
value of TOTPWR (TOTPWR > 11080.25 ms2 ), consistent with
the absence of statically significant differences between the two
patient groups.
The sets of rules of both the models are clinically consis-
tent, even if CART does not use any medical priori knowledge.
In fact, the main clinical result of this research is that termi-
nal node classifying as HRPs are on the left, thereby revealing
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Fig. 1. Final model tree for the combination of HRV features: TOTPWR,
pNN50, pNN10, and SDNNIDX.
Fig. 2. Final model tree for the combination of HRV features: ULF, TOTPWR,
and pNN50.
lower values of the splitting features for severe CHF patients
(with the only exception of pNN50). This is coherent with
the statistical analysis performed in the current study and
with the results showed by Casolo et al. [18], Panina [6] and
Arbolishvili [12]. It should be emphasized that the findings of
Casolo et al. [18], Panina et al. [6], and Arbolishvili et al. [12]
were obtained adopting different methods for PSD estimation.
Several methods were proposed in literature in order to estimate
PSD of RR intervals [4], [5]. Particularly, many PSD estimators
are based on the hypothesis that the signal under examination is
uniformly sampled [36]. In contrast, the RR series is unevenly
sampled and requires resampling before PSD estimation. In this
paper, LS periodogram [35] was chosen as it estimates PSD of
unevenly sampled signals without the requisite of resampling
and its estimation has been proven to be more accurate than fast
Fourier transform (FFT)-based method for RR data [40].
In relation to the methodology, the exhaustive research for
feature selection improved the classification performance com-
pared to CART model obtained using all the features. More-
over, as the study dataset is imbalanced, we compared the per-
formance of the proposed method with SMOTE, an approach
based on oversampling to handle the class-imbalance problem
and with other two widely used decision-tree methods. The pro-
posed method achieved the highest performance in terms of
accuracy rate and F1 , which is one of the most suitable metrics
for rare class problems [41]. Compared to our previous studies,
based on short-term measures [22], the classifier proposed in
the current studies achieved an higher accuracy and sensitivity
(85.4% versus 79.3% and 93.3% versus 82.4%, respectively),
even if with a lower specificity (75.0% versus 63.6%). This result
leaded us to consider long-term HRV measures more effective
for the individuation of higher risk patients than short-term ones.
As regards the other classifier proposed in literature for CHF
assessment, Guidi [23] compared different algorithms to auto-
matically classify CHF patients in three groups (mild, moder-
ate, and severe) and achieved an accuracy of 86% (indepen-
dent set estimate; sensitivity and sensibility are not reported)
by using neural network. Yang et al. [24] proposed a classifier
based on support-vector machine, which achieved an accuracy
of 74% (tenfold cross-validation estimate) in discriminating be-
tween mild CHF (NYHA I) and moderate/severe CHF patients
(NYHA II and III). We underline that the classifier proposed by
Guidi [23] was based on anamnestic and instrumental data (not
including HRV measures), and the one by Yang et al. [24] was
based on 12 parameters, including LF/HF and other parameters
from clinical tests (blood test, echocardiography test, electrocar-
diography test, chest radiography test, and 6-min walk distance
test). For that reason, some parameters needed by the automatic
classifier proposed by Guidi [23] or Yang et al. [24] should be
entered by physicians, while the adoption of only HRV mea-
sures, as in the current study, enables a completely automatic
assessment.
Our study had the following limitations related to the em-
ployed Holter databases: 1) a small and unbalanced dataset;
2) the differences in the sampling frequency of ECG record-
ings; and 3) the different extraction procedures of NN intervals
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(for instance, some recordings were not manually reviewed and
incorrect RR detections due to artifact may occur).
The small sample size could result in biased cross-validated
performance estimates, even if we adopted strategies (feature
selection and tree pruning) to avoid overfitting and to increase
the generalization ability. A study with a larger dataset would
be useful to confirm the generalization of our findings. Unfor-
tunately, to the best of the authors’ knowledge, a larger public
dataset is not available and the choice of only public databases
(and freely available HRV software) enables other researchers
to reproduce our results and compare different classification
methods.
As regards the imbalanced dataset problem, we adopted a
standard approach (oversampling) as a benchmark to compare
the proposed method, as previously described.
As regards the sampling frequency of ECG, it should be re-
membered that finite sampling frequency introduces an error
in the RR interval measurement, as previously shown by Merri
et al. [42]. However, a sampling rate of 128 Hz, which is the low-
est sampling rate of the recordings used in this paper, has been
found to be accurate enough to locate the R-peaks and, hence,
compute HRV [5]. Finally, in order to handle unreliable RR
interval measurements due to artifacts, following previous stud-
ies, the automated outlier removal provided by the adopted soft-
ware was performed and a measure of data reliability (NN/RR)
was adopted to discard unreliable results, as described in
Section II. In the future research, we are planning to develop a
similar study on a larger (although nonpublic) dataset of ECG
recordings digitalized at the same sampling frequency and an-
notated with a stated procedure, i.e., the database of Regione
Campania Network [43]. Moreover, nonlinear [44], [45] and/or
point process time-frequency [46] analysis could provide addi-
tional useful measures for automatic classification. Finally, the
classification algorithms could be integrated in portable sensing
devices [47]–[49].
We conclude that the long-term HRV measures enable higher
risk patients to be distinguished from lower risk ones. The clas-
sification trees developed achieved an accuracy rate of 85.4%,
a sensitivity rate of 93.3% and a specificity rate of 63.6%
(tenfold cross-validation estimates) using the combination of
features “TOTPWR, pNN10, pNN50, SDNNIDX” and “ULF,
TOTPWR, PNN50.” Finally, our results are consistent with the
consensus that depressed HRV values are associated with higher
cardiovascular risk.
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